Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients

Thumbnail
View/ Open

Show full item record

Author
Martelli, Alberto M.; Lonetti, Annalisa; Amadori, Sergio; McCubrey, James A.; Chiarini, Francesca
URI
http://hdl.handle.net/10342/5688
Subject
 autophagy; apoptosis; cell cycle; targeted therapy; translation; combination therapy; PI3K/Akt/mTOR; leukemia initiating cells 
Date
2013-06
Citation:
APA:
Martelli, Alberto M., & Lonetti, Annalisa, & Amadori, Sergio, & McCubrey, James A., & Chiarini, Francesca. (June 2013). Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients. Cell Cycle, (12:12), p.1815-1816. Retrieved from http://hdl.handle.net/10342/5688

Display/Hide MLA, Chicago and APA citation formats.

MLA:
Martelli, Alberto M., and Lonetti, Annalisa, and Amadori, Sergio, and McCubrey, James A., and Chiarini, Francesca. "Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients". Cell Cycle. 12:12. (1815-1816.), June 2013. December 10, 2022. http://hdl.handle.net/10342/5688.
Chicago:
Martelli, Alberto M. and Lonetti, Annalisa and Amadori, Sergio and McCubrey, James A. and Chiarini, Francesca, "Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients," Cell Cycle 12, no. 12 (June 2013), http://hdl.handle.net/10342/5688 (accessed December 10, 2022).
AMA:
Martelli, Alberto M., Lonetti, Annalisa, Amadori, Sergio, McCubrey, James A., Chiarini, Francesca. Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients. Cell Cycle. June 2013; 12(12) 1815-1816. http://hdl.handle.net/10342/5688. Accessed December 10, 2022.
Collections